Jon Anderson, CEO, Nothing Artificial on Why Healthcare Adopts Economic Inevitability

In this episode of #TheShot of Digital Health Therapy, Jim Joyce and I sit down with Jonathan Anderson, CEO of Nothing Artificial. Thoroughly enjoyed reconnecting and chatting across numerous topics: -The Door-to-Door Sales Rule: What Jon learned in his early days of selling home water systems to households (Hint: make sure all the decision makers are present at once) -The Enterprise Arbitrage: How Jon acquired UCB Pharma’s FDA-registered Nile.ai platform turning enterprise infrastructure into a commercial launchpad. -The DTx Graveyard Realist: Why Akili and Pear struggled, and why digital therapeutics must shift from standalone "disease apps" to cognitive infrastructure embedded directly into pharma pipelines and everyday hardware. -Economic Inevitability vs. Hype: Why health systems don't adopt tech because it's novel or slick - they adopt when friction drops to zero and the business model becomes mathematically unavoidable. Ready to hear how real health-tech deals get structured when the PR filter is off? Listen to the full episode on Spotify, Apple Podcasts, or YouTube below (links are in the comments) ! 👇 Fun mentions as always: Pia Clinton-Tarestad, Dominick Kennerson, Anil S Jina, MD , Eddie Martucci, David Benshoof Klein, Cris De Luca ⚽️, William Taranto 00:00:00 - The "Vibe Coded" Shelf & Improv Jazz Strategy 00:03:00 - 12 Siblings, Potato Fields, and the 14-Day Corporate Quit 00:10:30 - The Door-to-Door Water Filter Sales Masterclass 00:17:00 - Buying a Lab Project: 120 Studies, 51 Patents, and Manchester United 00:26:00 - The FDA Regulatory Path: Concussions, MCI, and Biomarkers 00:32:00 - The DTx Graveyard & The Akili Connection 00:41:00 - The $31M UCB Entity: Acquiring Nile.ai 00:46:00 - The 10-Year Horizon: Brain Health as the Next Vital Sign 00:54:00 - The Younger Self Advice: Economic Inevitability vs. Innovation Hype